Long-Term Outcomes of Systemic Lupus Erythematous Patients after Pregnancy: A Nationwide Population-Based Cohort Study.

Data on long-term maternal outcomes in patients with systemic lupus erythematosus (SLE) are lacking. The study aimed to explore the relationships among SLE, pregnancy, outcomes of end-stage renal disease (ESRD), and overall mortality.We established a retrospective cohort study consisting of four coh...

Full description

Bibliographic Details
Main Authors: Ting-Fang Chiu, Ya-Wen Chuang, Cheng-Li Lin, Tung-Min Yu, Mu-Chi Chung, Chi-Yuan Li, Chi-Jung Chung, Wen-Chao Ho
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2016-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC5167320?pdf=render
_version_ 1829519448842698752
author Ting-Fang Chiu
Ya-Wen Chuang
Cheng-Li Lin
Tung-Min Yu
Mu-Chi Chung
Chi-Yuan Li
Chi-Jung Chung
Wen-Chao Ho
author_facet Ting-Fang Chiu
Ya-Wen Chuang
Cheng-Li Lin
Tung-Min Yu
Mu-Chi Chung
Chi-Yuan Li
Chi-Jung Chung
Wen-Chao Ho
author_sort Ting-Fang Chiu
collection DOAJ
description Data on long-term maternal outcomes in patients with systemic lupus erythematosus (SLE) are lacking. The study aimed to explore the relationships among SLE, pregnancy, outcomes of end-stage renal disease (ESRD), and overall mortality.We established a retrospective cohort study consisting of four cohorts: pregnant (case cohort) and nonpregnant SLE patients, as well as pregnant and nonpregnant non-SLE patients. One case cohort and three comparison cohorts were matched by age at first pregnancy and index date of pregnancy by using the Taiwan National Health Insurance Research Dataset. All study subjects were selected based on the index date to the occurrence of ESRD or overall death. Cox proportional hazard regression models and Kaplan-Meier curves were used in the analysis.SLE pregnant patients exhibited significantly increased risk of ESRD after adjusting for other important confounders, including immunosuppressant and parity (HR = 3.19, 95% CI: 1.35-7.52 for pregnant non-SLE; and HR = 2.77, 95% CI: 1.24-6.15 for nonpregnant non-SLE patients). No significant differences in ESRD incidence were observed in pregnant and nonpregnant SLE patients. Pregnant SLE patients exhibited better clinical condition at the baseline and a significantly lower risk of overall mortality than nonpregnant SLE patients.Our data support current recommendations for SLE patients to avoid pregnancy until disease activity is quiescent. Multicenter recruitment and clinical information can be used to further examine the association of SLE and ESRD (or mortality) after pregnancy.
first_indexed 2024-12-16T14:39:23Z
format Article
id doaj.art-8c58e093f7d440719b4ae33f4451c111
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-16T14:39:23Z
publishDate 2016-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-8c58e093f7d440719b4ae33f4451c1112022-12-21T22:28:00ZengPublic Library of Science (PLoS)PLoS ONE1932-62032016-01-011112e016794610.1371/journal.pone.0167946Long-Term Outcomes of Systemic Lupus Erythematous Patients after Pregnancy: A Nationwide Population-Based Cohort Study.Ting-Fang ChiuYa-Wen ChuangCheng-Li LinTung-Min YuMu-Chi ChungChi-Yuan LiChi-Jung ChungWen-Chao HoData on long-term maternal outcomes in patients with systemic lupus erythematosus (SLE) are lacking. The study aimed to explore the relationships among SLE, pregnancy, outcomes of end-stage renal disease (ESRD), and overall mortality.We established a retrospective cohort study consisting of four cohorts: pregnant (case cohort) and nonpregnant SLE patients, as well as pregnant and nonpregnant non-SLE patients. One case cohort and three comparison cohorts were matched by age at first pregnancy and index date of pregnancy by using the Taiwan National Health Insurance Research Dataset. All study subjects were selected based on the index date to the occurrence of ESRD or overall death. Cox proportional hazard regression models and Kaplan-Meier curves were used in the analysis.SLE pregnant patients exhibited significantly increased risk of ESRD after adjusting for other important confounders, including immunosuppressant and parity (HR = 3.19, 95% CI: 1.35-7.52 for pregnant non-SLE; and HR = 2.77, 95% CI: 1.24-6.15 for nonpregnant non-SLE patients). No significant differences in ESRD incidence were observed in pregnant and nonpregnant SLE patients. Pregnant SLE patients exhibited better clinical condition at the baseline and a significantly lower risk of overall mortality than nonpregnant SLE patients.Our data support current recommendations for SLE patients to avoid pregnancy until disease activity is quiescent. Multicenter recruitment and clinical information can be used to further examine the association of SLE and ESRD (or mortality) after pregnancy.http://europepmc.org/articles/PMC5167320?pdf=render
spellingShingle Ting-Fang Chiu
Ya-Wen Chuang
Cheng-Li Lin
Tung-Min Yu
Mu-Chi Chung
Chi-Yuan Li
Chi-Jung Chung
Wen-Chao Ho
Long-Term Outcomes of Systemic Lupus Erythematous Patients after Pregnancy: A Nationwide Population-Based Cohort Study.
PLoS ONE
title Long-Term Outcomes of Systemic Lupus Erythematous Patients after Pregnancy: A Nationwide Population-Based Cohort Study.
title_full Long-Term Outcomes of Systemic Lupus Erythematous Patients after Pregnancy: A Nationwide Population-Based Cohort Study.
title_fullStr Long-Term Outcomes of Systemic Lupus Erythematous Patients after Pregnancy: A Nationwide Population-Based Cohort Study.
title_full_unstemmed Long-Term Outcomes of Systemic Lupus Erythematous Patients after Pregnancy: A Nationwide Population-Based Cohort Study.
title_short Long-Term Outcomes of Systemic Lupus Erythematous Patients after Pregnancy: A Nationwide Population-Based Cohort Study.
title_sort long term outcomes of systemic lupus erythematous patients after pregnancy a nationwide population based cohort study
url http://europepmc.org/articles/PMC5167320?pdf=render
work_keys_str_mv AT tingfangchiu longtermoutcomesofsystemiclupuserythematouspatientsafterpregnancyanationwidepopulationbasedcohortstudy
AT yawenchuang longtermoutcomesofsystemiclupuserythematouspatientsafterpregnancyanationwidepopulationbasedcohortstudy
AT chenglilin longtermoutcomesofsystemiclupuserythematouspatientsafterpregnancyanationwidepopulationbasedcohortstudy
AT tungminyu longtermoutcomesofsystemiclupuserythematouspatientsafterpregnancyanationwidepopulationbasedcohortstudy
AT muchichung longtermoutcomesofsystemiclupuserythematouspatientsafterpregnancyanationwidepopulationbasedcohortstudy
AT chiyuanli longtermoutcomesofsystemiclupuserythematouspatientsafterpregnancyanationwidepopulationbasedcohortstudy
AT chijungchung longtermoutcomesofsystemiclupuserythematouspatientsafterpregnancyanationwidepopulationbasedcohortstudy
AT wenchaoho longtermoutcomesofsystemiclupuserythematouspatientsafterpregnancyanationwidepopulationbasedcohortstudy